deferasirox has been researched along with Acute Kidney Failure in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aparicio López, C; Cervera Bravo, Á; Niño Taravilla, C; Otaola Arca, H; Sevilla, J | 1 |
| Dohi, K; Hirabayashi, Y; Hirota, Y; Ishikawa, E; Ito, M; Ito, T; Katayama, K; Mizoguchi, S; Murata, T; Oda, K; Tanoue, A | 1 |
| Barrette, S; Files, B; Habr, D; Minniti, CP; Torres, M; Vichinsky, E; Zhang, Y | 1 |
| Chou, HC; Hsiao, FY; Huang, WF; Tsai, YW | 1 |
| Díaz-García, JD; Gallegos-Villalobos, A; Gonzalez-Espinoza, L; Ortiz, A; Sanchez-Niño, MD; Villarrubia, J | 1 |
| Bruch, HR; Dencausse, Y; Heßling, J; Michl, G; Schlag, R; Schneider-Schranz, C; Schulte, C; Skorupa, A; Tesch, H; Wolf, S | 1 |
| Bennett, W; Coppo, R; Hirschberg, R; Ponticelli, C; Scheinman, J | 1 |
| Kontoghiorghes, GJ | 2 |
| Bertrand, DM; Eas, F; Godin, M; Grangé, S; Guerrot, D | 1 |
| Brown, M; Clayton, P; D'Rozario, J; Falk, MC; Talaulikar, GS; Yew, CT | 1 |
| Cho, EJ; Chueh, HW; Kim, JY; Koo, HH; Lee, SH; Sung, KW; Yoo, KH | 1 |
1 review(s) available for deferasirox and Acute Kidney Failure
| Article | Year |
|---|---|
Deferasirox nephrotoxicity-the knowns and unknowns.
Topics: Acute Kidney Injury; Benzoates; Deferasirox; Glomerular Filtration Rate; Humans; Iron Chelating Agents; Iron Overload; Renal Insufficiency, Chronic; Transfusion Reaction; Triazoles | 2014 |
3 trial(s) available for deferasirox and Acute Kidney Failure
| Article | Year |
|---|---|
Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.
Topics: Acute Kidney Injury; Adolescent; Adult; Anemia, Sickle Cell; Benzoates; Cellulitis; Chelation Therapy; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Deferasirox; Deferoxamine; Drug Therapy, Combination; Female; Ferritins; Humans; Hydroxyurea; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Prospective Studies; Transfusion Reaction; Triazoles; Young Adult | 2013 |
CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Benzoates; Deferasirox; Dose-Response Relationship, Drug; Drug Monitoring; Female; Gastrointestinal Diseases; Humans; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Myelodysplastic Syndromes; Transfusion Reaction; Treatment Outcome; Triazoles | 2016 |
Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.
Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles | 2012 |
8 other study(ies) available for deferasirox and Acute Kidney Failure
| Article | Year |
|---|---|
[Deferasirox and Complex Proximal Tubulopathy. Presentation of two clinical cases].
Topics: Acute Kidney Injury; Adolescent; Anemia, Diamond-Blackfan; Benzoates; Child, Preschool; Deferasirox; Female; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Triazoles | 2021 |
Acute kidney injury due to thin basement membrane disease mimicking Deferasirox nephrotoxicity: a case report.
Topics: Acute Kidney Injury; Deferasirox; Diagnosis, Differential; Glomerular Basement Membrane; Hematuria; Humans; Iron Chelating Agents; Kidney Tubules; Male; Middle Aged; Necrosis | 2018 |
Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Benzoates; Chemical and Drug Induced Liver Injury; Deferasirox; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Necrosis; Proportional Hazards Models; Retrospective Studies; Taiwan; Triazoles | 2014 |
Acute kidney injury due to deferoxamine in a renal transplant patient.
Topics: Acute Kidney Injury; Benzoates; Creatinine; Deferasirox; Deferoxamine; Humans; Kidney Transplantation; Siderophores; Triazoles | 2008 |
Transparency and access to full information for the fatal or serious toxicity risks, low efficacy and high price of deferasirox, could increase the prospect of improved iron chelation therapy worldwide.
Topics: Acute Kidney Injury; Benzoates; Chelation Therapy; Cost-Benefit Analysis; Deferasirox; Deferiprone; Deferoxamine; Drug Costs; Drug Industry; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Transfusion Reaction; Triazoles; Truth Disclosure | 2008 |
Acute renal failure and Fanconi syndrome due to deferasirox.
Topics: Acute Kidney Injury; Aged; Benzoates; Chronic Disease; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Triazoles | 2010 |
Acute interstitial nephritis secondary to deferasirox causing acute renal injury needing short-term dialysis.
Topics: Acute Kidney Injury; Aged; Benzoates; Biopsy; Deferasirox; Glucocorticoids; Humans; Iron Chelating Agents; Male; Nephritis, Interstitial; Prednisolone; Renal Dialysis; Time Factors; Treatment Outcome; Triazoles | 2010 |
Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities.
Topics: Acute Kidney Injury; Agranulocytosis; Benzoates; Chelating Agents; Deferasirox; Humans; Iron; Product Surveillance, Postmarketing; Triazoles | 2007 |